Showing recent highlights
What's New
PubMed · September 8, 2026
Researchers found that coating a person's own red blood cells with proteins found in myelin — the protective layer around nerve fibers that MS damages — and infusing them back into the body may help "teach" the immune system to stop attacking itself, which is the core problem in MS. In a small early-stage study, this approach appeared safe, kept disease measures stable, and triggered the growth of immune cells that calm down the attack rather than fuel it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that taking probiotics — the beneficial bacteria found in supplements and some foods — may help reduce fatigue, pain, and certain markers of inflammation in people with multiple sclerosis (MS). The analysis combined results from six small studies involving 282 people and found these physical benefits, though improvements in mood or overall disability levels were not clearly seen. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a structured group therapy program focused on managing emotions helped people with a form of multiple sclerosis (MS) — a disease that affects the brain and nervous system — who were also living with excess weight. Participants who went through the 14-session program showed improvements in anxiety, depression, emotional eating, and even some physical health measures like body weight, compared to those who received standard medical care alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that among people with multiple sclerosis (MS) who appeared clinically stable — meaning they had no new symptoms or flare-ups — about 1 in 8 still developed new lesions (areas of damage) in their spinal cord that showed up on MRI scans but caused no noticeable symptoms. For those with the most common form of MS, called relapsing-remitting MS, that number was even higher, closer to 1 in 5. This matters because it suggests that silent disease activity may be happening in the spinal cord even when a person feels fine, which could have implications for how closely doctors monitor the spine over time. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a diabetes medication like Ozempic or Victoza may have properties that reduce inflammation and protect nerve cells, which has sparked interest in whether it could one day help people with multiple sclerosis (MS) — a condition where the immune system mistakenly attacks the protective coating around nerves. In animal studies, these medications consistently reduced the severity of MS-like disease, and in a small number of human studies, people with MS who took these medications showed some health benefits, though no clear improvement in MS symptoms or relapse rates was seen. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that certain types of exercise — specifically resistance training, Pilates, and high-intensity interval training (HIIT) — were linked to lower levels of a protein in the blood called neurofilament light chain, which is a marker of nerve damage, in people with multiple sclerosis (MS). This is meaningful because lower levels of this marker may suggest that nerve cells are being damaged less, though it's important to know that not all exercise types showed this effect — longer, moderate aerobic exercise did not produce the same result. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · September 1, 2026
According to the French OFSEP guidelines, doctors caring for people with multiple sclerosis (MS) should now follow an updated set of recommendations for how MRI brain and spinal cord scans are performed and interpreted. These guidelines bring French practice in line with the latest 2024 McDonald criteria — the internationally agreed standards used to diagnose MS — and now recognize the optic nerve (the nerve connecting the eye to the brain) as an important area to examine, while also incorporating two newer scan markers that help confirm an MS diagnosis more precisely and reduce the chance of misdiagnosis. Importantly, the guidelines also recommend limiting the use of gadolinium — a contrast dye injected during some MRI scans — to only specific situations, which is good news for patients since this reduces unnecessary exposure to the dye.
What's New
PubMed · September 1, 2026
Researchers found that people with multiple sclerosis who combined 12 weeks of exercise with a nightly melatonin supplement saw greater improvements in inflammation, body composition, and certain markers of cellular stress compared to those who only exercised or only took melatonin — suggesting the two approaches may work better together than either one alone. Multiple sclerosis is a condition where the immune system mistakenly attacks the nervous system, and managing inflammation is an important part of living well with it. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should consider trying melatonin supplements along with exercise training, since a study found that this combination helped people with multiple sclerosis reduce inflammation and improve their body composition.
Guidelines
PubMed · September 1, 2026
According to the German Society of Neuroradiology (DGNR) guidelines, endorsed by the German Society of Neurology (DGN), doctors diagnosing and monitoring multiple sclerosis (MS) — a condition where the immune system attacks the brain and nerves — should now use updated MRI scanning approaches that look at more areas of the body, including the optic nerve (the nerve connecting the eye to the brain), to help identify MS earlier and more accurately. These guidelines also highlight new MRI markers, such as certain types of lesions (areas of damage visible on a brain scan), that can give doctors a clearer picture of how the disease is behaving over time. Getting the diagnosis right sooner matters because it allows people with MS to begin appropriate care as early as possible.
What's New
PubMed · September 1, 2026
A study found that strength-based exercise — things like lifting weights or using resistance bands — may improve overall quality of life for people with multiple sclerosis (MS), a condition where the immune system mistakenly attacks the nervous system, affecting movement and energy. Researchers looked at 13 studies and found improvements in both physical well-being and, to a lesser extent, emotional well-being, though the mental health benefits weren't consistent enough to be considered statistically reliable. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · September 1, 2026
A study found that people with multiple sclerosis (MS) who also experience significant anxiety felt noticeably calmer and in a better mood after just 20 minutes of moderate-paced walking on a treadmill — and those benefits were still present 20 minutes after the walk ended. Researchers compared the walking session to simply sitting quietly, and only the walking produced these improvements in anxiety and mood. This suggests that a single, relatively short walk may offer real emotional relief for people with MS who struggle with anxiety.
What's New
PubMed · September 1, 2026
Researchers found that smoking did not clearly speed up physical disability in people with multiple sclerosis — meaning it didn't consistently make it harder to walk or move around over time. However, the research hinted that smokers with MS may experience worse fatigue, lower quality of life, and a harder time recovering from relapses (flare-ups of symptoms). This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 27, 2026
Researchers found that vestibular rehabilitation — a type of exercise therapy that trains the brain and body to better handle balance and dizziness — helped people with multiple sclerosis walk faster, stay steadier on their feet, and feel less dizzy, fatigued, and depressed, compared to those who received standard care or no special treatment. These findings come from combining the results of 13 separate studies involving 454 people with MS, which gives the results more weight than a single study alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 22, 2026
Researchers found that two special MRI scan features — tiny iron-rimmed spots and lesions with a vein running through their center — appear frequently in children and teens diagnosed with multiple sclerosis, a disease where the immune system mistakenly attacks the nervous system. These features may help doctors tell MS apart from other conditions that can look similar on a brain scan, which is especially important in younger patients where getting the diagnosis right quickly matters. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 7, 2026
Researchers found that nearly half of all people with multiple sclerosis (MS) experience neurogenic bladder — a condition where nerve damage from MS disrupts normal bladder control, causing problems like urgency, leaking, or difficulty emptying the bladder fully. This was consistent across different ages and stages of the disease, suggesting bladder problems are a widespread concern throughout the MS journey, not just in later or more severe cases. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 6, 2026
Researchers found that gut problems are surprisingly common in people with multiple sclerosis (MS) — a disease where the immune system damages nerves in the brain and spinal cord. For example, about 1 in 3 people with MS experienced issues where their digestive system wasn't working properly on its own, like trouble swallowing or bowel problems, and people with MS were more than three times as likely to have these issues compared to people without MS. This matters because gut symptoms can seriously affect daily life, and recognizing them as a real part of MS may help patients and their doctors address them more proactively. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that a protein in the blood called neurofilament light chain — which leaks into the bloodstream when nerve cells are damaged — may help doctors track whether multiple sclerosis is active or getting worse, without needing more invasive tests. Looking at 28 studies involving over 11,000 patients, researchers found this blood marker shows real promise for detecting disease flare-ups, though results varied quite a bit across different studies, making it hard to settle on one reliable threshold for what counts as a 'high' level. This matters because a simple blood test that reliably signals nerve damage could eventually help doctors catch worsening MS earlier and adjust care more quickly. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that fingolimod, a medication used to treat multiple sclerosis (MS) in children and teens, significantly reduced the number of MS flare-ups — episodes where symptoms suddenly worsen — by about one relapse per year compared to before treatment. Nearly 80% of young patients were still taking the medication after two years, suggesting many tolerated it well, though side effects like infections, headaches, and low white blood cell counts (cells the body uses to fight illness) were reported in some patients. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that people who smoke cigarettes or waterpipes (like a hookah) appear to have a higher chance of developing multiple sclerosis (MS), a condition where the immune system mistakenly attacks the nervous system, and may also see their MS get worse more quickly over time — especially those who have smoked heavily for many years. The more a person smoked, the greater the risk seemed to be, suggesting the amount smoked may matter, not just whether someone smokes at all. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that taking high doses of vitamin D (at least 10,000 IU per day) appeared to be surprisingly safe for people with multiple sclerosis (MS), a disease where the immune system mistakenly attacks the nervous system — which can cause disability over time. The high doses successfully raised vitamin D levels in the blood, and serious side effects like high calcium levels were rare and short-lived, though the results on whether it actually slowed the disease were mixed across studies. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
A study found that people with multiple sclerosis (MS) — a condition where the body's immune system damages the protective coating around nerve fibers, affecting thinking and movement — who followed a MIND diet (a brain-focused eating pattern rich in vegetables, berries, nuts, and fish) for 12 weeks showed improvements in their diet quality, and those who stuck most closely to the diet also showed signs of better attention and spatial memory (the ability to remember where things are). The study was small, with only 40 participants, and was mainly designed to test whether this kind of remote diet program was practical to run rather than to prove the diet works. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that exercise appears to help people with severe multiple sclerosis (MS) — a condition where the immune system damages nerves, affecting movement, thinking, and daily life — by improving physical fitness, how well the body functions, and overall quality of life. Looking at 29 studies involving over 1,100 people, the researchers found that most exercise programs led to improvements in at least one area, though exercise did not seem to slow the level of disability itself. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
Researchers found that a single 20-minute walking session changed how certain parts of the brain communicate with each other in people with multiple sclerosis (MS) — a condition where the immune system damages the nervous system, often affecting thinking and movement. Specifically, walking outdoors on the ground seemed to boost connections in brain areas linked to higher-level thinking, while walking on a treadmill boosted connections in areas linked to visual processing; the thalamus, a brain region that acts like a relay station passing signals between different areas, was at the center of these changes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 1, 2026
A study found that people with multiple sclerosis (MS, a condition where the immune system attacks the nervous system) who did a special low-intensity exercise program for 12 weeks reported less anxiety and depression, and felt better about their overall quality of life compared to those who didn't do the program. The exercise involved gentle resistance training — like light weightlifting — using a technique called blood flow restriction, which temporarily limits blood flow to the muscles so they work harder even at low intensity. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 29, 2026
Researchers found that people living with Alzheimer's disease and several other brain conditions may be at a higher risk of suicidal thoughts or attempts, with depression and feeling socially isolated being the most common warning signs. Interestingly, the pattern in Alzheimer's was less clear than in other conditions studied, making it harder to pinpoint when people might be most vulnerable. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 27, 2026
Researchers found that exercise significantly reduced pain in people with multiple sclerosis (MS), a condition where the immune system attacks the nervous system. Looking at 22 studies focused on MS, they found that people who exercised experienced notably less pain compared to those who didn't, suggesting movement may work as a natural, drug-free way to manage one of MS's most challenging symptoms. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 22, 2026
Researchers found that music-based therapies — things like moving or walking in time to a beat, or imagining movement while listening to music — may help people with multiple sclerosis (MS) walk better, covering more distance, moving more evenly, and at a steadier pace. This was the most consistent finding across 23 studies involving hundreds of people with MS. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 20, 2026
A study is looking at whether a program called iStep-MS — which encourages people with multiple sclerosis (MS) to move more and sit less throughout their day — can help reduce fatigue, one of the most exhausting and life-disrupting symptoms of MS. The program involves four personal sessions with a healthcare provider over three months, and researchers are testing it across a range of NHS and charity-funded care settings in England. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 15, 2026
Researchers found that more than half of people with mild-to-moderate multiple sclerosis (MS) — a condition where the immune system damages nerves, often affecting movement and balance — reported falling at least once over just three months, which can seriously affect their safety and independence. A study is looking at whether creating a personalized fall prevention plan with a physiotherapist, one tailored to each person's specific MS symptoms and daily habits, works better than giving everyone the same general fall-safety tips. This matters because falls are a major concern for people living with MS, and a more targeted approach could potentially help reduce them. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 13, 2026
Researchers found that a brain stimulation technique called tDCS — where a gentle electrical current is applied to the scalp through small electrodes — may help improve leg movement and balance in people with multiple sclerosis, with those receiving stronger stimulation for 20 minutes seeing the most benefit. Specifically, people showed improvements in how far they could walk and how steadily they could stand still, though walking speed and hand coordination didn't improve as much. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.